nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP1A1—breast cancer	0.152	0.42	CbGaD
Chlorzoxazone—CYP2D6—breast cancer	0.113	0.312	CbGaD
Chlorzoxazone—CYP3A4—breast cancer	0.0967	0.268	CbGaD
Chlorzoxazone—CYP2A6—Letrozole—breast cancer	0.0789	0.167	CbGbCtD
Chlorzoxazone—CYP1A1—Toremifene—breast cancer	0.055	0.116	CbGbCtD
Chlorzoxazone—CYP1A2—Anastrozole—breast cancer	0.0269	0.0568	CbGbCtD
Chlorzoxazone—CYP1A2—Toremifene—breast cancer	0.0246	0.052	CbGbCtD
Chlorzoxazone—CYP2A6—Tamoxifen—breast cancer	0.0235	0.0497	CbGbCtD
Chlorzoxazone—CYP1A1—Tamoxifen—breast cancer	0.0201	0.0425	CbGbCtD
Chlorzoxazone—CYP3A4—Exemestane—breast cancer	0.0186	0.0393	CbGbCtD
Chlorzoxazone—CYP2A6—Fluorouracil—breast cancer	0.0173	0.0367	CbGbCtD
Chlorzoxazone—CYP2D6—Idarubicin—breast cancer	0.0168	0.0355	CbGbCtD
Chlorzoxazone—CYP3A4—Letrozole—breast cancer	0.0158	0.0334	CbGbCtD
Chlorzoxazone—CYP2E1—Tamoxifen—breast cancer	0.0155	0.0328	CbGbCtD
Chlorzoxazone—CYP2E1—Mitoxantrone—breast cancer	0.0151	0.032	CbGbCtD
Chlorzoxazone—CYP3A4—Anastrozole—breast cancer	0.0141	0.0298	CbGbCtD
Chlorzoxazone—CYP3A4—Toremifene—breast cancer	0.0129	0.0272	CbGbCtD
Chlorzoxazone—CYP3A4—Fulvestrant—breast cancer	0.012	0.0253	CbGbCtD
Chlorzoxazone—CYP3A4—Thiotepa—breast cancer	0.0107	0.0226	CbGbCtD
Chlorzoxazone—CYP3A4—Ixabepilone—breast cancer	0.00975	0.0206	CbGbCtD
Chlorzoxazone—CYP3A4—Lapatinib—breast cancer	0.00939	0.0199	CbGbCtD
Chlorzoxazone—CYP1A2—Tamoxifen—breast cancer	0.00897	0.019	CbGbCtD
Chlorzoxazone—CYP2D6—Vinorelbine—breast cancer	0.00819	0.0173	CbGbCtD
Chlorzoxazone—CYP2D6—Tamoxifen—breast cancer	0.00739	0.0156	CbGbCtD
Chlorzoxazone—CYP3A4—Raloxifene—breast cancer	0.00711	0.0151	CbGbCtD
Chlorzoxazone—CYP1A2—Fluorouracil—breast cancer	0.00661	0.014	CbGbCtD
Chlorzoxazone—CYP3A4—Vinorelbine—breast cancer	0.00521	0.011	CbGbCtD
Chlorzoxazone—CYP2D6—Vinblastine—breast cancer	0.00505	0.0107	CbGbCtD
Chlorzoxazone—CYP3A4—Tamoxifen—breast cancer	0.0047	0.00995	CbGbCtD
Chlorzoxazone—CYP3A4—Mitoxantrone—breast cancer	0.00458	0.0097	CbGbCtD
Chlorzoxazone—CYP3A4—Paclitaxel—breast cancer	0.00366	0.00774	CbGbCtD
Chlorzoxazone—CYP3A4—Irinotecan—breast cancer	0.00361	0.00764	CbGbCtD
Chlorzoxazone—CYP3A4—Vinblastine—breast cancer	0.00321	0.00679	CbGbCtD
Chlorzoxazone—CYP2D6—Doxorubicin—breast cancer	0.0031	0.00656	CbGbCtD
Chlorzoxazone—CYP3A4—Docetaxel—breast cancer	0.00264	0.0056	CbGbCtD
Chlorzoxazone—Urine color abnormal—Mitoxantrone—breast cancer	0.0025	0.0335	CcSEcCtD
Chlorzoxazone—Digestion impaired—Fulvestrant—breast cancer	0.00237	0.0317	CcSEcCtD
Chlorzoxazone—CYP3A4—Doxorubicin—breast cancer	0.00197	0.00417	CbGbCtD
Chlorzoxazone—Digestion impaired—Anastrozole—breast cancer	0.00183	0.0244	CcSEcCtD
Chlorzoxazone—Urine color abnormal—Capecitabine—breast cancer	0.00167	0.0224	CcSEcCtD
Chlorzoxazone—Chromaturia—Mitoxantrone—breast cancer	0.00165	0.0221	CcSEcCtD
Chlorzoxazone—Digestion impaired—Chlorambucil—breast cancer	0.0014	0.0188	CcSEcCtD
Chlorzoxazone—Digestion impaired—Melphalan—breast cancer	0.00122	0.0164	CcSEcCtD
Chlorzoxazone—Chromaturia—Capecitabine—breast cancer	0.0011	0.0148	CcSEcCtD
Chlorzoxazone—Lightheadedness—Letrozole—breast cancer	0.00109	0.0146	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Ixabepilone—breast cancer	0.000941	0.0126	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Fluoxymesterone—breast cancer	0.000864	0.0116	CcSEcCtD
Chlorzoxazone—Lightheadedness—Tamoxifen—breast cancer	0.000747	0.01	CcSEcCtD
Chlorzoxazone—Ecchymosis—Goserelin—breast cancer	0.000721	0.00965	CcSEcCtD
Chlorzoxazone—Petechiae—Mitoxantrone—breast cancer	0.000716	0.00958	CcSEcCtD
Chlorzoxazone—Petechiae—Gemcitabine—breast cancer	0.000698	0.00934	CcSEcCtD
Chlorzoxazone—Angioedema—Fulvestrant—breast cancer	0.000632	0.00845	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Lapatinib—breast cancer	0.000613	0.00821	CcSEcCtD
Chlorzoxazone—Malaise—Exemestane—breast cancer	0.000541	0.00725	CcSEcCtD
Chlorzoxazone—Dyspepsia—Lapatinib—breast cancer	0.00054	0.00723	CcSEcCtD
Chlorzoxazone—Ecchymosis—Mitoxantrone—breast cancer	0.000533	0.00713	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Lapatinib—breast cancer	0.00053	0.00709	CcSEcCtD
Chlorzoxazone—Dyspepsia—Fulvestrant—breast cancer	0.000497	0.00665	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Anastrozole—breast cancer	0.000495	0.00662	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Letrozole—breast cancer	0.000495	0.00662	CcSEcCtD
Chlorzoxazone—Angioedema—Letrozole—breast cancer	0.000487	0.00652	CcSEcCtD
Chlorzoxazone—Angioedema—Anastrozole—breast cancer	0.000487	0.00652	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Fulvestrant—breast cancer	0.000487	0.00652	CcSEcCtD
Chlorzoxazone—Malaise—Anastrozole—breast cancer	0.000481	0.00644	CcSEcCtD
Chlorzoxazone—Malaise—Letrozole—breast cancer	0.000481	0.00644	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Toremifene—breast cancer	0.000481	0.00643	CcSEcCtD
Chlorzoxazone—Petechiae—Capecitabine—breast cancer	0.000479	0.00641	CcSEcCtD
Chlorzoxazone—Discomfort—Anastrozole—breast cancer	0.000449	0.00601	CcSEcCtD
Chlorzoxazone—Discomfort—Letrozole—breast cancer	0.000449	0.00601	CcSEcCtD
Chlorzoxazone—Drowsiness—Goserelin—breast cancer	0.000446	0.00597	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Letrozole—breast cancer	0.000435	0.00583	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Anastrozole—breast cancer	0.000435	0.00583	CcSEcCtD
Chlorzoxazone—Dyspepsia—Exemestane—breast cancer	0.000431	0.00577	CcSEcCtD
Chlorzoxazone—Lightheadedness—Paclitaxel—breast cancer	0.00043	0.00575	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Mitoxantrone—breast cancer	0.000428	0.00572	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Irinotecan—breast cancer	0.000428	0.00572	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Exemestane—breast cancer	0.000423	0.00566	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Idarubicin—breast cancer	0.000413	0.00553	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Fluorouracil—breast cancer	0.00041	0.00548	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Exemestane—breast cancer	0.000404	0.0054	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Ixabepilone—breast cancer	0.000399	0.00534	CcSEcCtD
Chlorzoxazone—Somnolence—Letrozole—breast cancer	0.000387	0.00518	CcSEcCtD
Chlorzoxazone—Somnolence—Anastrozole—breast cancer	0.000387	0.00518	CcSEcCtD
Chlorzoxazone—Rash—Lapatinib—breast cancer	0.000387	0.00518	CcSEcCtD
Chlorzoxazone—Dermatitis—Lapatinib—breast cancer	0.000386	0.00517	CcSEcCtD
Chlorzoxazone—Dyspepsia—Anastrozole—breast cancer	0.000383	0.00513	CcSEcCtD
Chlorzoxazone—Dyspepsia—Letrozole—breast cancer	0.000383	0.00513	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Anastrozole—breast cancer	0.000376	0.00503	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Letrozole—breast cancer	0.000376	0.00503	CcSEcCtD
Chlorzoxazone—Angioedema—Chlorambucil—breast cancer	0.000375	0.00502	CcSEcCtD
Chlorzoxazone—Dizziness—Fulvestrant—breast cancer	0.000373	0.00499	CcSEcCtD
Chlorzoxazone—Dizziness—Toremifene—breast cancer	0.000368	0.00493	CcSEcCtD
Chlorzoxazone—Lightheadedness—Docetaxel—breast cancer	0.000364	0.00488	CcSEcCtD
Chlorzoxazone—Dyspepsia—Raloxifene—breast cancer	0.000364	0.00487	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Letrozole—breast cancer	0.000359	0.0048	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Anastrozole—breast cancer	0.000359	0.0048	CcSEcCtD
Chlorzoxazone—Petechiae—Methotrexate—breast cancer	0.000357	0.00478	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Raloxifene—breast cancer	0.000357	0.00477	CcSEcCtD
Chlorzoxazone—Ecchymosis—Capecitabine—breast cancer	0.000357	0.00477	CcSEcCtD
Chlorzoxazone—Rash—Fulvestrant—breast cancer	0.000356	0.00476	CcSEcCtD
Chlorzoxazone—Dermatitis—Fulvestrant—breast cancer	0.000355	0.00476	CcSEcCtD
Chlorzoxazone—Rash—Toremifene—breast cancer	0.000351	0.0047	CcSEcCtD
Chlorzoxazone—Dermatitis—Toremifene—breast cancer	0.000351	0.00469	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Vinblastine—breast cancer	0.000349	0.00467	CcSEcCtD
Chlorzoxazone—Malaise—Vinblastine—breast cancer	0.000339	0.00454	CcSEcCtD
Chlorzoxazone—Petechiae—Epirubicin—breast cancer	0.000334	0.00447	CcSEcCtD
Chlorzoxazone—Angioedema—Tamoxifen—breast cancer	0.000334	0.00446	CcSEcCtD
Chlorzoxazone—Drowsiness—Mitoxantrone—breast cancer	0.00033	0.00441	CcSEcCtD
Chlorzoxazone—Dizziness—Exemestane—breast cancer	0.000324	0.00434	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Goserelin—breast cancer	0.000324	0.00433	CcSEcCtD
Chlorzoxazone—Discomfort—Vinblastine—breast cancer	0.000316	0.00423	CcSEcCtD
Chlorzoxazone—Malaise—Goserelin—breast cancer	0.000314	0.00421	CcSEcCtD
Chlorzoxazone—Rash—Exemestane—breast cancer	0.000309	0.00414	CcSEcCtD
Chlorzoxazone—Petechiae—Doxorubicin—breast cancer	0.000309	0.00414	CcSEcCtD
Chlorzoxazone—Dermatitis—Exemestane—breast cancer	0.000309	0.00413	CcSEcCtD
Chlorzoxazone—Discomfort—Tamoxifen—breast cancer	0.000307	0.00411	CcSEcCtD
Chlorzoxazone—Dizziness—Ixabepilone—breast cancer	0.000306	0.00409	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Docetaxel—breast cancer	0.000296	0.00396	CcSEcCtD
Chlorzoxazone—Dyspepsia—Chlorambucil—breast cancer	0.000295	0.00394	CcSEcCtD
Chlorzoxazone—Discomfort—Goserelin—breast cancer	0.000293	0.00393	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Melphalan—breast cancer	0.000292	0.0039	CcSEcCtD
Chlorzoxazone—Rash—Ixabepilone—breast cancer	0.000292	0.0039	CcSEcCtD
Chlorzoxazone—Dermatitis—Ixabepilone—breast cancer	0.000291	0.0039	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Vinorelbine—breast cancer	0.00029	0.00388	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Chlorambucil—breast cancer	0.000289	0.00387	CcSEcCtD
Chlorzoxazone—Dizziness—Letrozole—breast cancer	0.000288	0.00385	CcSEcCtD
Chlorzoxazone—Dizziness—Anastrozole—breast cancer	0.000288	0.00385	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Capecitabine—breast cancer	0.000286	0.00383	CcSEcCtD
Chlorzoxazone—Angioedema—Vinorelbine—breast cancer	0.000285	0.00382	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Goserelin—breast cancer	0.000285	0.00381	CcSEcCtD
Chlorzoxazone—Malaise—Vinorelbine—breast cancer	0.000282	0.00377	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Chlorambucil—breast cancer	0.000276	0.00369	CcSEcCtD
Chlorzoxazone—Rash—Letrozole—breast cancer	0.000275	0.00367	CcSEcCtD
Chlorzoxazone—Rash—Anastrozole—breast cancer	0.000275	0.00367	CcSEcCtD
Chlorzoxazone—Dermatitis—Letrozole—breast cancer	0.000274	0.00367	CcSEcCtD
Chlorzoxazone—Dermatitis—Anastrozole—breast cancer	0.000274	0.00367	CcSEcCtD
Chlorzoxazone—Dizziness—Raloxifene—breast cancer	0.000273	0.00366	CcSEcCtD
Chlorzoxazone—Ecchymosis—Methotrexate—breast cancer	0.000265	0.00355	CcSEcCtD
Chlorzoxazone—Discomfort—Vinorelbine—breast cancer	0.000263	0.00352	CcSEcCtD
Chlorzoxazone—Dyspepsia—Tamoxifen—breast cancer	0.000262	0.00351	CcSEcCtD
Chlorzoxazone—Rash—Idarubicin—breast cancer	0.000261	0.00349	CcSEcCtD
Chlorzoxazone—Rash—Raloxifene—breast cancer	0.000261	0.00349	CcSEcCtD
Chlorzoxazone—Dermatitis—Idarubicin—breast cancer	0.00026	0.00348	CcSEcCtD
Chlorzoxazone—Dermatitis—Raloxifene—breast cancer	0.00026	0.00348	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Tamoxifen—breast cancer	0.000257	0.00344	CcSEcCtD
Chlorzoxazone—Dyspepsia—Melphalan—breast cancer	0.000257	0.00344	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Vinorelbine—breast cancer	0.000255	0.00341	CcSEcCtD
Chlorzoxazone—Somnolence—Goserelin—breast cancer	0.000253	0.00339	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Vinblastine—breast cancer	0.000253	0.00338	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Melphalan—breast cancer	0.000252	0.00337	CcSEcCtD
Chlorzoxazone—Dyspepsia—Goserelin—breast cancer	0.000251	0.00335	CcSEcCtD
Chlorzoxazone—Ecchymosis—Epirubicin—breast cancer	0.000248	0.00332	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Mitoxantrone—breast cancer	0.000239	0.0032	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Irinotecan—breast cancer	0.000239	0.0032	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Goserelin—breast cancer	0.000235	0.00314	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Gemcitabine—breast cancer	0.000233	0.00312	CcSEcCtD
Chlorzoxazone—Malaise—Mitoxantrone—breast cancer	0.000232	0.00311	CcSEcCtD
Chlorzoxazone—Malaise—Irinotecan—breast cancer	0.000232	0.00311	CcSEcCtD
Chlorzoxazone—Ecchymosis—Doxorubicin—breast cancer	0.00023	0.00308	CcSEcCtD
Chlorzoxazone—Malaise—Gemcitabine—breast cancer	0.000226	0.00303	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Vinorelbine—breast cancer	0.00022	0.00295	CcSEcCtD
Chlorzoxazone—Discomfort—Mitoxantrone—breast cancer	0.000217	0.0029	CcSEcCtD
Chlorzoxazone—Discomfort—Irinotecan—breast cancer	0.000217	0.0029	CcSEcCtD
Chlorzoxazone—Somnolence—Thiotepa—breast cancer	0.000216	0.0029	CcSEcCtD
Chlorzoxazone—Dyspepsia—Thiotepa—breast cancer	0.000214	0.00287	CcSEcCtD
Chlorzoxazone—Discomfort—Gemcitabine—breast cancer	0.000211	0.00282	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Mitoxantrone—breast cancer	0.00021	0.00281	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Irinotecan—breast cancer	0.00021	0.00281	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Thiotepa—breast cancer	0.00021	0.00281	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Vinorelbine—breast cancer	0.00021	0.00281	CcSEcCtD
Chlorzoxazone—Discomfort—Fluorouracil—breast cancer	0.000208	0.00278	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Gemcitabine—breast cancer	0.000205	0.00274	CcSEcCtD
Chlorzoxazone—Dizziness—Vinblastine—breast cancer	0.000203	0.00271	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Fluorouracil—breast cancer	0.000201	0.00269	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Thiotepa—breast cancer	0.000201	0.00268	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Epirubicin—breast cancer	0.000199	0.00267	CcSEcCtD
Chlorzoxazone—Dizziness—Tamoxifen—breast cancer	0.000197	0.00264	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Paclitaxel—breast cancer	0.000195	0.00261	CcSEcCtD
Chlorzoxazone—Angioedema—Paclitaxel—breast cancer	0.000192	0.00257	CcSEcCtD
Chlorzoxazone—Malaise—Paclitaxel—breast cancer	0.000189	0.00254	CcSEcCtD
Chlorzoxazone—Dizziness—Goserelin—breast cancer	0.000188	0.00252	CcSEcCtD
Chlorzoxazone—Rash—Tamoxifen—breast cancer	0.000188	0.00251	CcSEcCtD
Chlorzoxazone—Dermatitis—Tamoxifen—breast cancer	0.000188	0.00251	CcSEcCtD
Chlorzoxazone—Somnolence—Irinotecan—breast cancer	0.000187	0.0025	CcSEcCtD
Chlorzoxazone—Somnolence—Mitoxantrone—breast cancer	0.000187	0.0025	CcSEcCtD
Chlorzoxazone—Dyspepsia—Mitoxantrone—breast cancer	0.000185	0.00248	CcSEcCtD
Chlorzoxazone—Dyspepsia—Irinotecan—breast cancer	0.000185	0.00248	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	0.000185	0.00247	CcSEcCtD
Chlorzoxazone—Rash—Melphalan—breast cancer	0.000184	0.00246	CcSEcCtD
Chlorzoxazone—Dermatitis—Melphalan—breast cancer	0.000184	0.00246	CcSEcCtD
Chlorzoxazone—Somnolence—Gemcitabine—breast cancer	0.000182	0.00244	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Irinotecan—breast cancer	0.000181	0.00243	CcSEcCtD
Chlorzoxazone—Rash—Goserelin—breast cancer	0.000179	0.0024	CcSEcCtD
Chlorzoxazone—Dermatitis—Goserelin—breast cancer	0.000179	0.0024	CcSEcCtD
Chlorzoxazone—Somnolence—Fluorouracil—breast cancer	0.000179	0.0024	CcSEcCtD
Chlorzoxazone—Dyspepsia—Fluorouracil—breast cancer	0.000177	0.00237	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000177	0.00237	CcSEcCtD
Chlorzoxazone—Discomfort—Paclitaxel—breast cancer	0.000177	0.00236	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000174	0.00233	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Mitoxantrone—breast cancer	0.000173	0.00232	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Irinotecan—breast cancer	0.000173	0.00232	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Paclitaxel—breast cancer	0.000171	0.00229	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Gemcitabine—breast cancer	0.000169	0.00226	CcSEcCtD
Chlorzoxazone—Dizziness—Vinorelbine—breast cancer	0.000169	0.00226	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Fluorouracil—breast cancer	0.000166	0.00222	CcSEcCtD
Chlorzoxazone—Drowsiness—Methotrexate—breast cancer	0.000164	0.0022	CcSEcCtD
Chlorzoxazone—Dizziness—Thiotepa—breast cancer	0.000161	0.00215	CcSEcCtD
Chlorzoxazone—Rash—Vinorelbine—breast cancer	0.000161	0.00215	CcSEcCtD
Chlorzoxazone—Dermatitis—Vinorelbine—breast cancer	0.000161	0.00215	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Capecitabine—breast cancer	0.00016	0.00214	CcSEcCtD
Chlorzoxazone—Malaise—Capecitabine—breast cancer	0.000155	0.00208	CcSEcCtD
Chlorzoxazone—Drowsiness—Epirubicin—breast cancer	0.000154	0.00206	CcSEcCtD
Chlorzoxazone—Rash—Thiotepa—breast cancer	0.000153	0.00205	CcSEcCtD
Chlorzoxazone—Dermatitis—Thiotepa—breast cancer	0.000153	0.00205	CcSEcCtD
Chlorzoxazone—Somnolence—Paclitaxel—breast cancer	0.000152	0.00204	CcSEcCtD
Chlorzoxazone—Dyspepsia—Paclitaxel—breast cancer	0.000151	0.00202	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000148	0.00198	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Docetaxel—breast cancer	0.000145	0.00194	CcSEcCtD
Chlorzoxazone—Discomfort—Capecitabine—breast cancer	0.000145	0.00194	CcSEcCtD
Chlorzoxazone—Drowsiness—Doxorubicin—breast cancer	0.000142	0.0019	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Paclitaxel—breast cancer	0.000141	0.00189	CcSEcCtD
Chlorzoxazone—Dizziness—Irinotecan—breast cancer	0.000139	0.00186	CcSEcCtD
Chlorzoxazone—Dizziness—Fluorouracil—breast cancer	0.000133	0.00178	CcSEcCtD
Chlorzoxazone—Rash—Mitoxantrone—breast cancer	0.000133	0.00177	CcSEcCtD
Chlorzoxazone—Rash—Irinotecan—breast cancer	0.000133	0.00177	CcSEcCtD
Chlorzoxazone—Dermatitis—Mitoxantrone—breast cancer	0.000132	0.00177	CcSEcCtD
Chlorzoxazone—Dermatitis—Irinotecan—breast cancer	0.000132	0.00177	CcSEcCtD
Chlorzoxazone—Somnolence—Docetaxel—breast cancer	0.000129	0.00173	CcSEcCtD
Chlorzoxazone—Rash—Gemcitabine—breast cancer	0.000129	0.00173	CcSEcCtD
Chlorzoxazone—Dermatitis—Gemcitabine—breast cancer	0.000129	0.00173	CcSEcCtD
Chlorzoxazone—Dyspepsia—Docetaxel—breast cancer	0.000128	0.00171	CcSEcCtD
Chlorzoxazone—Rash—Fluorouracil—breast cancer	0.000127	0.0017	CcSEcCtD
Chlorzoxazone—Dermatitis—Fluorouracil—breast cancer	0.000127	0.0017	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Docetaxel—breast cancer	0.000125	0.00168	CcSEcCtD
Chlorzoxazone—Dyspepsia—Capecitabine—breast cancer	0.000124	0.00166	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Capecitabine—breast cancer	0.000121	0.00163	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Docetaxel—breast cancer	0.00012	0.0016	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Methotrexate—breast cancer	0.000119	0.00159	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Capecitabine—breast cancer	0.000116	0.00155	CcSEcCtD
Chlorzoxazone—Malaise—Methotrexate—breast cancer	0.000116	0.00155	CcSEcCtD
Chlorzoxazone—Dizziness—Paclitaxel—breast cancer	0.000113	0.00152	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Epirubicin—breast cancer	0.000111	0.00149	CcSEcCtD
Chlorzoxazone—Malaise—Epirubicin—breast cancer	0.000108	0.00145	CcSEcCtD
Chlorzoxazone—Rash—Paclitaxel—breast cancer	0.000108	0.00145	CcSEcCtD
Chlorzoxazone—Dermatitis—Paclitaxel—breast cancer	0.000108	0.00145	CcSEcCtD
Chlorzoxazone—Discomfort—Methotrexate—breast cancer	0.000108	0.00144	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Methotrexate—breast cancer	0.000105	0.0014	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Doxorubicin—breast cancer	0.000103	0.00138	CcSEcCtD
Chlorzoxazone—Discomfort—Epirubicin—breast cancer	0.000101	0.00135	CcSEcCtD
Chlorzoxazone—Malaise—Doxorubicin—breast cancer	0.0001	0.00134	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Epirubicin—breast cancer	9.8e-05	0.00131	CcSEcCtD
Chlorzoxazone—Dizziness—Docetaxel—breast cancer	9.61e-05	0.00129	CcSEcCtD
Chlorzoxazone—Discomfort—Doxorubicin—breast cancer	9.35e-05	0.00125	CcSEcCtD
Chlorzoxazone—Somnolence—Methotrexate—breast cancer	9.31e-05	0.00125	CcSEcCtD
Chlorzoxazone—Dizziness—Capecitabine—breast cancer	9.3e-05	0.00125	CcSEcCtD
Chlorzoxazone—Dyspepsia—Methotrexate—breast cancer	9.22e-05	0.00123	CcSEcCtD
Chlorzoxazone—Rash—Docetaxel—breast cancer	9.16e-05	0.00123	CcSEcCtD
Chlorzoxazone—Dermatitis—Docetaxel—breast cancer	9.15e-05	0.00123	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Doxorubicin—breast cancer	9.07e-05	0.00121	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Methotrexate—breast cancer	9.04e-05	0.00121	CcSEcCtD
Chlorzoxazone—Rash—Capecitabine—breast cancer	8.87e-05	0.00119	CcSEcCtD
Chlorzoxazone—Dermatitis—Capecitabine—breast cancer	8.86e-05	0.00119	CcSEcCtD
Chlorzoxazone—Somnolence—Epirubicin—breast cancer	8.71e-05	0.00117	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Methotrexate—breast cancer	8.63e-05	0.00116	CcSEcCtD
Chlorzoxazone—Dyspepsia—Epirubicin—breast cancer	8.63e-05	0.00115	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Epirubicin—breast cancer	8.46e-05	0.00113	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Epirubicin—breast cancer	8.08e-05	0.00108	CcSEcCtD
Chlorzoxazone—Somnolence—Doxorubicin—breast cancer	8.06e-05	0.00108	CcSEcCtD
Chlorzoxazone—Dyspepsia—Doxorubicin—breast cancer	7.98e-05	0.00107	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Doxorubicin—breast cancer	7.83e-05	0.00105	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Doxorubicin—breast cancer	7.47e-05	0.001	CcSEcCtD
Chlorzoxazone—Dizziness—Methotrexate—breast cancer	6.93e-05	0.000927	CcSEcCtD
Chlorzoxazone—Rash—Methotrexate—breast cancer	6.6e-05	0.000884	CcSEcCtD
Chlorzoxazone—Dermatitis—Methotrexate—breast cancer	6.6e-05	0.000883	CcSEcCtD
Chlorzoxazone—Dizziness—Epirubicin—breast cancer	6.48e-05	0.000867	CcSEcCtD
Chlorzoxazone—Rash—Epirubicin—breast cancer	6.18e-05	0.000827	CcSEcCtD
Chlorzoxazone—Dermatitis—Epirubicin—breast cancer	6.17e-05	0.000826	CcSEcCtD
Chlorzoxazone—Dizziness—Doxorubicin—breast cancer	6e-05	0.000803	CcSEcCtD
Chlorzoxazone—Rash—Doxorubicin—breast cancer	5.72e-05	0.000765	CcSEcCtD
Chlorzoxazone—Dermatitis—Doxorubicin—breast cancer	5.71e-05	0.000765	CcSEcCtD
Chlorzoxazone—KCNMA1—epithelium—breast cancer	3.83e-05	0.0837	CbGeAlD
Chlorzoxazone—KCNMA1—uterus—breast cancer	3.16e-05	0.0692	CbGeAlD
Chlorzoxazone—KCNMA1—adipose tissue—breast cancer	3.09e-05	0.0677	CbGeAlD
Chlorzoxazone—KCNMA1—female reproductive system—breast cancer	2.84e-05	0.0622	CbGeAlD
Chlorzoxazone—KCNMA1—adrenal gland—breast cancer	2.77e-05	0.0607	CbGeAlD
Chlorzoxazone—CYP2A6—adipose tissue—breast cancer	2.58e-05	0.0565	CbGeAlD
Chlorzoxazone—CYP1A2—nipple—breast cancer	2.49e-05	0.0546	CbGeAlD
Chlorzoxazone—CYP1A1—nipple—breast cancer	2.46e-05	0.0538	CbGeAlD
Chlorzoxazone—KCNMA1—endocrine gland—breast cancer	2.41e-05	0.0526	CbGeAlD
Chlorzoxazone—KCNMA1—lymph node—breast cancer	1.66e-05	0.0364	CbGeAlD
Chlorzoxazone—CYP1A1—epithelium—breast cancer	1.66e-05	0.0362	CbGeAlD
Chlorzoxazone—CYP1A1—skin of body—breast cancer	1.58e-05	0.0345	CbGeAlD
Chlorzoxazone—CYP1A1—uterus—breast cancer	1.37e-05	0.0299	CbGeAlD
Chlorzoxazone—CYP1A1—adipose tissue—breast cancer	1.34e-05	0.0293	CbGeAlD
Chlorzoxazone—CYP1A1—female reproductive system—breast cancer	1.23e-05	0.0269	CbGeAlD
Chlorzoxazone—CYP2E1—female reproductive system—breast cancer	1.12e-05	0.0246	CbGeAlD
Chlorzoxazone—CYP1A1—female gonad—breast cancer	1.12e-05	0.0245	CbGeAlD
Chlorzoxazone—CYP2E1—adrenal gland—breast cancer	1.09e-05	0.024	CbGeAlD
Chlorzoxazone—CYP1A2—endocrine gland—breast cancer	1.06e-05	0.0231	CbGeAlD
Chlorzoxazone—CYP1A1—endocrine gland—breast cancer	1.04e-05	0.0228	CbGeAlD
Chlorzoxazone—CYP2E1—endocrine gland—breast cancer	9.5e-06	0.0208	CbGeAlD
Chlorzoxazone—CYP3A4—female reproductive system—breast cancer	9.03e-06	0.0198	CbGeAlD
Chlorzoxazone—CYP2D6—female reproductive system—breast cancer	8.88e-06	0.0194	CbGeAlD
Chlorzoxazone—CYP2D6—female gonad—breast cancer	8.08e-06	0.0177	CbGeAlD
Chlorzoxazone—CYP3A4—endocrine gland—breast cancer	7.64e-06	0.0167	CbGeAlD
Chlorzoxazone—CYP2D6—endocrine gland—breast cancer	7.52e-06	0.0165	CbGeAlD
Chlorzoxazone—CYP1A1—lymph node—breast cancer	7.2e-06	0.0158	CbGeAlD
Chlorzoxazone—CYP1A2—Metabolism—NAT2—breast cancer	5.24e-06	5.74e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GPX1—breast cancer	5.21e-06	5.71e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.18e-06	5.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NCOA3—breast cancer	5.18e-06	5.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP1A1—breast cancer	5.16e-06	5.66e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP3A4—breast cancer	5.16e-06	5.66e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SLC2A2—breast cancer	5.14e-06	5.64e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.14e-06	5.63e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NCOA1—breast cancer	5.13e-06	5.63e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ERCC2—breast cancer	5.12e-06	5.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—FHL2—breast cancer	5.11e-06	5.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NME1—breast cancer	5.11e-06	5.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—UMPS—breast cancer	5.11e-06	5.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ADSL—breast cancer	5.11e-06	5.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PHGDH—breast cancer	5.11e-06	5.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP1B1—breast cancer	5.07e-06	5.56e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—STK11—breast cancer	5.06e-06	5.55e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP19A1—breast cancer	5.06e-06	5.55e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ABCG2—breast cancer	5.04e-06	5.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CPT1A—breast cancer	5.04e-06	5.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—MTR—breast cancer	5.04e-06	5.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—LDHB—breast cancer	5.01e-06	5.5e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HPSE—breast cancer	5.01e-06	5.5e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—BRIP1—breast cancer	5.01e-06	5.5e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—HSP90AA1—breast cancer	4.98e-06	5.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HPGDS—breast cancer	4.94e-06	5.42e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HBA1—breast cancer	4.91e-06	5.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NCOA1—breast cancer	4.84e-06	5.31e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—MTHFR—breast cancer	4.81e-06	5.27e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ACHE—breast cancer	4.79e-06	5.25e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTT1—breast cancer	4.79e-06	5.25e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—STK11—breast cancer	4.77e-06	5.23e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP19A1—breast cancer	4.77e-06	5.23e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTA3—breast cancer	4.75e-06	5.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HMMR—breast cancer	4.75e-06	5.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ABCC1—breast cancer	4.75e-06	5.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.73e-06	5.19e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—COMT—breast cancer	4.7e-06	5.16e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTP1—breast cancer	4.68e-06	5.13e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—HMOX1—breast cancer	4.62e-06	5.06e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ITPR1—breast cancer	4.61e-06	5.05e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.6e-06	5.05e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MED12—breast cancer	4.59e-06	5.03e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—DPYD—breast cancer	4.59e-06	5.03e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP17A1—breast cancer	4.54e-06	4.97e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ALDOA—breast cancer	4.52e-06	4.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ENO1—breast cancer	4.49e-06	4.92e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PTGS1—breast cancer	4.49e-06	4.92e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.48e-06	4.91e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CAV1—breast cancer	4.44e-06	4.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—COMT—breast cancer	4.44e-06	4.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ABCB1—breast cancer	4.43e-06	4.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTP1—breast cancer	4.41e-06	4.84e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NCOA3—breast cancer	4.39e-06	4.81e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC2A2—breast cancer	4.36e-06	4.78e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—HMOX1—breast cancer	4.35e-06	4.77e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—TYMS—breast cancer	4.35e-06	4.77e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTA4—breast cancer	4.35e-06	4.77e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CA9—breast cancer	4.35e-06	4.77e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ITPR1—breast cancer	4.34e-06	4.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NCOA2—breast cancer	4.32e-06	4.74e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.31e-06	4.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PLA2G4A—breast cancer	4.3e-06	4.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NCOR1—breast cancer	4.3e-06	4.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTM1—breast cancer	4.3e-06	4.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ABCG2—breast cancer	4.27e-06	4.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CPT1A—breast cancer	4.27e-06	4.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MTR—breast cancer	4.27e-06	4.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GPX2—breast cancer	4.24e-06	4.64e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTA2—breast cancer	4.24e-06	4.64e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—FASN—breast cancer	4.19e-06	4.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HPGDS—breast cancer	4.19e-06	4.59e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SULT1A1—breast cancer	4.18e-06	4.59e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GPX4—breast cancer	4.18e-06	4.59e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ABCB1—breast cancer	4.18e-06	4.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—BCHE—breast cancer	4.18e-06	4.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HBA1—breast cancer	4.16e-06	4.56e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SLC5A5—breast cancer	4.12e-06	4.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GPX1—breast cancer	4.12e-06	4.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—TYMS—breast cancer	4.1e-06	4.5e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—IDH1—breast cancer	4.09e-06	4.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTA1—breast cancer	4.09e-06	4.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP1A1—breast cancer	4.08e-06	4.47e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ACHE—breast cancer	4.06e-06	4.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTT1—breast cancer	4.06e-06	4.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTM1—breast cancer	4.06e-06	4.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NCOR1—breast cancer	4.06e-06	4.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PLA2G4A—breast cancer	4.06e-06	4.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ERCC2—breast cancer	4.05e-06	4.43e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CG—breast cancer	4.04e-06	4.43e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NAT2—breast cancer	4.04e-06	4.43e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NQO1—breast cancer	3.98e-06	4.37e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SLC2A1—breast cancer	3.98e-06	4.37e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP3A4—breast cancer	3.88e-06	4.26e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GPX1—breast cancer	3.88e-06	4.26e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP17A1—breast cancer	3.84e-06	4.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP1B1—breast cancer	3.82e-06	4.19e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ERCC2—breast cancer	3.81e-06	4.18e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PTGS1—breast cancer	3.81e-06	4.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ENO1—breast cancer	3.81e-06	4.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—MTHFR—breast cancer	3.8e-06	4.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.79e-06	4.16e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.75e-06	4.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.74e-06	4.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP2D6—breast cancer	3.73e-06	4.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NCOA2—breast cancer	3.66e-06	4.01e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NCOA1—breast cancer	3.64e-06	3.99e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—STK11—breast cancer	3.59e-06	3.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP19A1—breast cancer	3.59e-06	3.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—MTHFR—breast cancer	3.59e-06	3.93e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CD—breast cancer	3.55e-06	3.9e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—FASN—breast cancer	3.55e-06	3.89e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MED12—breast cancer	3.54e-06	3.88e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—DPYD—breast cancer	3.54e-06	3.88e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—BCHE—breast cancer	3.54e-06	3.88e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ALB—breast cancer	3.51e-06	3.85e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CAV1—breast cancer	3.51e-06	3.84e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC5A5—breast cancer	3.49e-06	3.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ALDOA—breast cancer	3.49e-06	3.82e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NCOA3—breast cancer	3.39e-06	3.71e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NQO1—breast cancer	3.37e-06	3.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC2A1—breast cancer	3.37e-06	3.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC2A2—breast cancer	3.36e-06	3.69e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NOS3—breast cancer	3.36e-06	3.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—COMT—breast cancer	3.34e-06	3.66e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTP1—breast cancer	3.32e-06	3.64e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CAV1—breast cancer	3.31e-06	3.62e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.3e-06	3.62e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MTR—breast cancer	3.29e-06	3.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CPT1A—breast cancer	3.29e-06	3.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ABCG2—breast cancer	3.29e-06	3.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP3A4—breast cancer	3.29e-06	3.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HMOX1—breast cancer	3.28e-06	3.59e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.27e-06	3.59e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ITPR1—breast cancer	3.27e-06	3.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP1B1—breast cancer	3.24e-06	3.55e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HPGDS—breast cancer	3.23e-06	3.54e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HBA1—breast cancer	3.21e-06	3.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CG—breast cancer	3.19e-06	3.5e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.17e-06	3.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.16e-06	3.46e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ABCB1—breast cancer	3.15e-06	3.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTT1—breast cancer	3.13e-06	3.43e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ACHE—breast cancer	3.13e-06	3.43e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CB—breast cancer	3.1e-06	3.4e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—TYMS—breast cancer	3.09e-06	3.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NCOA1—breast cancer	3.09e-06	3.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PTGS2—breast cancer	3.07e-06	3.36e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.05e-06	3.35e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTM1—breast cancer	3.05e-06	3.35e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NCOR1—breast cancer	3.05e-06	3.35e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—STK11—breast cancer	3.04e-06	3.33e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP19A1—breast cancer	3.04e-06	3.33e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CG—breast cancer	3.01e-06	3.3e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP17A1—breast cancer	2.97e-06	3.25e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ENO1—breast cancer	2.94e-06	3.22e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PTGS1—breast cancer	2.94e-06	3.22e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GPX1—breast cancer	2.92e-06	3.2e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP1A1—breast cancer	2.89e-06	3.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP2D6—breast cancer	2.88e-06	3.16e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ERCC2—breast cancer	2.87e-06	3.15e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.86e-06	3.13e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—COMT—breast cancer	2.83e-06	3.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NCOA2—breast cancer	2.83e-06	3.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTP1—breast cancer	2.81e-06	3.08e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CD—breast cancer	2.81e-06	3.08e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HMOX1—breast cancer	2.78e-06	3.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ALB—breast cancer	2.77e-06	3.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ITPR1—breast cancer	2.77e-06	3.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—FASN—breast cancer	2.74e-06	3e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—BCHE—breast cancer	2.73e-06	2.99e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—MTHFR—breast cancer	2.7e-06	2.96e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC5A5—breast cancer	2.7e-06	2.96e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PTEN—breast cancer	2.68e-06	2.93e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ABCB1—breast cancer	2.66e-06	2.92e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NOS3—breast cancer	2.65e-06	2.91e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CD—breast cancer	2.65e-06	2.9e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—TYMS—breast cancer	2.62e-06	2.87e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ALB—breast cancer	2.61e-06	2.87e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NQO1—breast cancer	2.6e-06	2.85e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC2A1—breast cancer	2.6e-06	2.85e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTM1—breast cancer	2.59e-06	2.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NCOR1—breast cancer	2.59e-06	2.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.59e-06	2.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NOS3—breast cancer	2.5e-06	2.74e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP1B1—breast cancer	2.5e-06	2.74e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CAV1—breast cancer	2.49e-06	2.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GPX1—breast cancer	2.48e-06	2.71e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP1A1—breast cancer	2.45e-06	2.69e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.45e-06	2.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CB—breast cancer	2.45e-06	2.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ERCC2—breast cancer	2.43e-06	2.67e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PTGS2—breast cancer	2.43e-06	2.66e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NCOA1—breast cancer	2.38e-06	2.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—STK11—breast cancer	2.35e-06	2.57e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP19A1—breast cancer	2.35e-06	2.57e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CB—breast cancer	2.31e-06	2.53e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PTGS2—breast cancer	2.29e-06	2.51e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MTHFR—breast cancer	2.29e-06	2.51e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CG—breast cancer	2.27e-06	2.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—COMT—breast cancer	2.18e-06	2.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTP1—breast cancer	2.17e-06	2.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HMOX1—breast cancer	2.14e-06	2.35e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ITPR1—breast cancer	2.14e-06	2.34e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PTEN—breast cancer	2.12e-06	2.32e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CAV1—breast cancer	2.11e-06	2.31e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ABCB1—breast cancer	2.06e-06	2.25e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—TYMS—breast cancer	2.02e-06	2.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.01e-06	2.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NCOR1—breast cancer	2e-06	2.19e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTM1—breast cancer	2e-06	2.19e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PLA2G4A—breast cancer	2e-06	2.19e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PTEN—breast cancer	1.99e-06	2.19e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CD—breast cancer	1.99e-06	2.18e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ALB—breast cancer	1.97e-06	2.16e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CG—breast cancer	1.92e-06	2.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GPX1—breast cancer	1.91e-06	2.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP1A1—breast cancer	1.89e-06	2.07e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CA—breast cancer	1.89e-06	2.07e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NOS3—breast cancer	1.88e-06	2.06e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ERCC2—breast cancer	1.88e-06	2.06e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MTHFR—breast cancer	1.76e-06	1.93e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CB—breast cancer	1.74e-06	1.9e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PTGS2—breast cancer	1.72e-06	1.89e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CD—breast cancer	1.69e-06	1.85e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ALB—breast cancer	1.67e-06	1.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CAV1—breast cancer	1.63e-06	1.78e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NOS3—breast cancer	1.59e-06	1.75e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—AKT1—breast cancer	1.54e-06	1.69e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PTEN—breast cancer	1.5e-06	1.65e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CA—breast cancer	1.49e-06	1.64e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CG—breast cancer	1.48e-06	1.62e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CB—breast cancer	1.47e-06	1.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PTGS2—breast cancer	1.46e-06	1.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CA—breast cancer	1.41e-06	1.54e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CD—breast cancer	1.3e-06	1.43e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ALB—breast cancer	1.29e-06	1.41e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PTEN—breast cancer	1.27e-06	1.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NOS3—breast cancer	1.23e-06	1.35e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—AKT1—breast cancer	1.22e-06	1.34e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—AKT1—breast cancer	1.15e-06	1.26e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CB—breast cancer	1.14e-06	1.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PTGS2—breast cancer	1.13e-06	1.23e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CA—breast cancer	1.06e-06	1.16e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PTEN—breast cancer	9.81e-07	1.08e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CA—breast cancer	8.97e-07	9.83e-06	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—AKT1—breast cancer	8.65e-07	9.48e-06	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—AKT1—breast cancer	7.33e-07	8.03e-06	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CA—breast cancer	6.92e-07	7.59e-06	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AKT1—breast cancer	5.66e-07	6.2e-06	CbGpPWpGaD
